YAP1 and lung cancer: SCD1 has been widely studied in metabolic diseases, such as diabetes and obesity.29,30 In addition, some studies have indicated the biological role of SCD1 in solid tumours, such as hepatocellular cancer and lung cancer,31,32 either through ER stress or the Hippo/Yap pathway.